Keyuan Pharmaceutical Keyuan Pharmaceutical

Stock Code: 301281
Confirm
Service Platform

Raw material API CMO/CDMO business

Formulation CMO/CDMO business

Medical beauty material CMO/CDMO business

Featured pilot platform

Raw material API CMO/CDMO business

Why Choose CMO/CDMO?

(1) Institutional Permits: The Drug Listing Applicant (MAH) system has decoupled "R&D + Production," boosting R&D enthusiasm, accelerating new drug launches, and improving efficiency.

(2) Comprehensive Optimization: CMO/CDMO organizations possess multiple new technology platforms, extensive development experience, robust quality systems, and strong intellectual property protection. They can comprehensively consider various factors such as drug synthesis, drug formability, and review and approval risks for iterative optimization.

(3) Cost Control: CMO/CDMO services help clients flexibly shift production capacity pressures, reducing the effort and expense required to transfer experimental products to factory workshops, thereby lowering costs.

Why Choose Keyuan?

Keyuan Pharmaceutical—Rooted in China, Connected Globally: Your API CMO/CDMO partner, using international certifications as a passport and intelligent factories as the engine, accelerating your molecule's journey from lab to market!
(1) As a leading domestic API company, Keyuan Pharmaceutical holds over 20 core API process patents. We can handle hazardous processes such as sulfonation, nitration, hydrogenation, oxidation, and chlorination, as well as hormone/fermentation product production, providing full-chain empowerment from molecular development to commercialization.
(2) We have established a certification system covering major global markets, providing international compliance assurance for API CMO/CDMO services:
(3) Multiple core products have passed China NMPA GMP, US FDA, and EU CEP certifications and have been officially audited and approved by Canada, Japan, Korea, etc., possessing global registration qualifications.
(4) International Project Experience: We have established strategic partnerships with numerous multinational pharmaceutical companies, successfully supplying internationally renowned cosmetic raw materials (CMO model) and undertaking high-end API orders from Europe and the US.